Perinatally HIV-infected youth presenting with acute stroke: progression/evolution of ischemic disease on neuroimaging.

BACKGROUND AND PURPOSE Although HIV infection is decreasing in infants and children, there is a steady cohort of perinatally HIV-infected (PHIV) children that are growing older. Increased risk of acute stroke has been reported in PHIV children. Our goal was to evaluate evolution/progression of neuroimaging findings in PHIV youth initially presenting with acute stroke. MATERIALS AND METHODS The medical records of PHIV pediatric patients (n = 179) from 1996 to 2010 were reviewed and patients with clinical documentation of acute stroke referred to the neuroradiology service were eligible for the study. Neuroimaging (brain CT, MRI, and MRA) and charts were evaluated; clinical and neuroimaging findings at the initial acute stroke and at the last presentation to the neuroradiology service were documented and analyzed. RESULTS Eight PHIV patients with clinical findings of acute stroke referred to the neuroimaging were identified. CT and MRI findings of infarction were found in all (8/8) patients in their first and/or last neuroimaging study; including basal ganglia-thalami (BGT) infarction (7/8), focal cortical infarction (4/8), and internal capsule infarction (4/8). Imaging depicted cortical atrophy (5/8), BGT calcification (3/8), and posterior reversible encephalopathy syndrome, wallerian degeneration, and periventricular white matter hyperintense T2 signal each in one patient. No tumors or infectious masses, cysts or abscesses were identified. Subsequent available neuroimaging revealed progression of the cerebrovascular disease in seven patients, 5/7 in the absence of new clinical signs or symptoms. Segmental occlusion, narrowing or narrowing/dilatation in the circle of Willis was found in 6/6 patients who underwent MR angiography and fusiform aneurysms were detected in three of them, a saccular aneurysm in one patient. CONCLUSION Asymptomatic progression of cerebrovascular disease was found in PHIV adolescents with prior stroke. These findings may have implications for long-term risk and outcomes for this patient population. There should be a low threshold to evaluate for CNS pathology even with minor symptoms in this population. More studies are necessary to determine if there is a benefit from screening of asymptomatic patients.

[1]  J. Phair,et al.  Association Between Human Immunodeficiency Virus Infection and Stiffness of the Common Carotid Artery , 2010, Stroke.

[2]  C. Rudin,et al.  Calcifying arteriopathy in the basal ganglia in human immunodeficiency virus infection , 2005, Pediatric Radiology.

[3]  W. Mitchell Neurological and developmental effects of HIV and AIDS in children and adolescents. , 2001, Mental retardation and developmental disabilities research reviews.

[4]  M. Fowler,et al.  Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children , 1996 .

[5]  N. Patronas,et al.  Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings. , 2002, AJR. American journal of roentgenology.

[6]  J. Crawford,et al.  Advances in Pediatric Neurovirology , 2010, Current neurology and neuroscience reports.

[7]  M. Cortina-Borja,et al.  Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990–2007 , 2009, AIDS.

[8]  D. Dickson,et al.  AIDS: Calcification of the basal ganglia in infants and children , 1986, Neurology.

[9]  J. Berman,et al.  Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. , 2008, The American journal of pathology.

[10]  C. Fitz,et al.  CT and MR evaluation of intracranial involvement in pediatric HIV infection: a clinical-imaging correlation. , 1992, AJNR. American journal of neuroradiology.

[11]  M. Connor Human immunodeficiency virus (HIV) and stroke: targets for intervention. , 2010, Infectious disorders drug targets.

[12]  E. Engels Non-0002030-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities , 2009, AIDS.

[13]  L. Mofenson,et al.  Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection. , 2010, Annual review of medicine.

[14]  R. Yogev,et al.  Central Nervous System Abnormalities in Pediatric Human Immunodeficiency Virus Infection , 1999, Pediatric Neurosurgery.

[15]  S. A. Thomas,et al.  Anti-HIV drug distribution to the central nervous system. , 2004, Current pharmaceutical design.

[16]  J. Gutierrez,et al.  HIV/AIDS Patients with HIV Vasculopathy and VZV Vasculitis , 2011, Clinical Neuroradiology.

[17]  P. Lin,et al.  Current Update on HIV-associated Vascular Disease and Endothelial Dysfunction , 2007, World Journal of Surgery.

[18]  R. Tubiana,et al.  Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Berger,et al.  Stroke in HIV infection and AIDS , 2009, Expert review of cardiovascular therapy.

[20]  C. Petito,et al.  Cerebral aneurysmal arteriopathy in childhood AIDS , 1998, Neurology.

[21]  C. Sabin,et al.  Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy. , 2008, Circulation.

[22]  C. Amlie-Lefond,et al.  Neurologic manifestations of varicella zoster virus infections , 2009, Current neurology and neuroscience reports.

[23]  H. Lanfermann,et al.  MRI in human immunodeficiency virus-associated cerebral vasculitis , 2000, Neuroradiology.

[24]  D. Clifford,et al.  Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance , 2009, AIDS.

[25]  M. Sanada,et al.  Multiple cerebral aneurysms caused by HIV-associated vasculopathy. , 2010, Internal medicine.